School of Medicine, University of Utah, Salt Lake City, UT, USA.
Department of Neurosurgery, University of New Mexico Hospital, Albuquerque, NM, USA.
Eur J Surg Oncol. 2022 Jul;48(7):1671-1677. doi: 10.1016/j.ejso.2022.02.015. Epub 2022 Feb 11.
The objective of this study was to compare the effect of frailty, as measured by the 5-factor modified frailty index (mFI-5), with that of age on postoperative outcomes of patients undergoing surgery for intracranial meningiomas, using data from a large national registry.
The National Surgical Quality Improvement Program (NSQIP) database (2015-2019) was queried to analyze data from patients undergoing intracranial meningioma resection (N = 5,818). Univariate and multivariate analyses of age and mFI-5 score were performed for 30-day mortality, major complications, unplanned reoperation, unplanned readmission, extended hospital length of stay (eLOS), and discharge to a non-home destination.
Both univariate and multivariate analyses (adjusted for sex, body mass index, transfer status, smoking, and operative time) demonstrated that mFI-5 and age were significant predictors of adverse postoperative outcomes in patients with intracranial meningioma. However, based on odds ratios (OR) and effect sizes, increasing frailty tiers were better predictors than age of adverse outcomes. Severely frail patients showed highest effects sizes for all postoperative outcome variables [OR 11.17 (95% CI 3.45-36.19), p<0.001 for mortality; OR 4.15 (95% CI 2.46-6.99), p<0.001 for major complications; OR 4.37 (95% CI 2.68-7.12), p<0.001 for unplanned readmission; OR 2.31 (95% CI 1.17-4.55), p<0.001 for unplanned reoperation; OR 4.28 (95% CI 2.74-6.68), p<0.001 for eLOS; and OR 9.34 (95% CI 6.03-14.47, p<0.001) for discharge other than home.
In this national database study, baseline frailty status was a better independent predictor for worse postoperative outcomes than age in patients with intracranial meningioma.
本研究旨在通过利用大型国家注册数据库的数据,比较 5 项修正虚弱指数(mFI-5)评估的虚弱程度与年龄对颅内脑膜瘤患者术后结局的影响。
对国家外科质量改进计划(NSQIP)数据库(2015-2019 年)进行检索,分析了 5818 例行颅内脑膜瘤切除术患者的数据。对年龄和 mFI-5 评分进行单因素和多因素分析,以评估 30 天死亡率、主要并发症、非计划再次手术、非计划再入院、延长住院时间(eLOS)和出院至非家庭目的地的情况。
单因素和多因素分析(校正性别、体重指数、转移状态、吸烟和手术时间)均表明,mFI-5 和年龄是颅内脑膜瘤患者术后不良结局的显著预测因素。然而,基于优势比(OR)和效应量,虚弱程度增加的分层比年龄更能预测不良结局。严重虚弱患者在所有术后结局变量中表现出最高的效应量[死亡的 OR 为 11.17(95%置信区间 3.45-36.19),p<0.001;主要并发症的 OR 为 4.15(95%置信区间 2.46-6.99),p<0.001;非计划再入院的 OR 为 4.37(95%置信区间 2.68-7.12),p<0.001;非计划再次手术的 OR 为 2.31(95%置信区间 1.17-4.55),p<0.001;eLOS 的 OR 为 4.28(95%置信区间 2.74-6.68),p<0.001;出院非家庭目的地的 OR 为 9.34(95%置信区间 6.03-14.47),p<0.001]。
在这项全国性数据库研究中,与颅内脑膜瘤患者相比,基线虚弱状态是术后结局更差的独立预测因素,优于年龄。